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RESULTS
• An additional 5 animal were given 2· 0 ml. SKCF intramuscuIarly for 10-14 days
without operation.
TABLE 1. SURVIVAL RATES IN TREATED AND UNTREATED BABOON
RENAL AllOGRAITS
Survival
The average survival time following renal allotrans-
plantation of the 6 untreated control animals from non-
inbred groups was 9·7 ± 5·6 day before uraemic death
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mals were injected with 2·0 m!. SKCF for 10 - 14 days,
during which time specimens for erythropoietin as ay
were obtained; no change in haematocrit or renal func-
tion was noted in the group during this period.
Erythropoietin (ESF) assays were completed, as pre-
viously described, by injection of plasma samples into
polycythaemic adult Ha/lCR Swiss mice.'· Each test
mouse received ubcutaneous injections of 0·5 m!. of
pia ma daily for 3 successive days. On the fourth day
they were injected intravenously with 1 p'c of ""Fe in 0·5
m!. saline. Twenty-four hours later they were bled from
the dorsal aorta, and the radioactivity of the blood sample
was measured in a well-type scintillation counter. The re-
sults were expressed as the percentage of the 24-hour in-
corporation of radioactive iron into the circulating red
cells. Re ults were also expressed as the ratio of ~~ ""Fe
24-hour uptake (test plasma) / ~~ "Fe 24-hour uptake
(saline-injected controls). Assays from mice with haema-
tocrit levels less than 60~~ at the end of the experiment
were discarded. Over 5 animals were as ayed with each
test plasma.
animals in any of the groups that died from technical
problems uch as thrombosis of the vascular anastomoses.
All animals died a a result of renal allograft rejection as
was confirmed at postmortem examination. Subsequent
microscopic studie demonstrated characteristic vascular
and cellular features as ociated with baboon renal allo-
graft rejection, such as interstitial and perivascular
lymphocytic collections and obliterations of small
arterioles." The second group of 9 animals that received
SKCF 2·0 m!. intramuscularly on alternate days survived
Subcellular kidney cell fraction
(SKCF)*
(2'0 ml. intramu cularly)




Erythropoietin (E F) i a hormone active in the regula-
tion of red blood cell production.' It is normally of renal
origin. although extrarenal sources have been demon-
strated.,,3 Autotransplanted imian< and canine kidney
grafts" release ESF in response to arterial occlusion, hy-
poxic hypoxia or bleeding. Baboon and simian kidney
allografts also release ESF in large amounts during graft
rejection."': This report de cribes ESF alterations in un-
treated baboon and in animal given ubcellular kidney
cell fraction (SKCF) to uppre rejection.
MATERIALS ND METHODS
Twenty-one healthy adult male and female Cape Chacma
baboon, housed and cared for at the University of
Stellenbosch Primate Facility at Karl Bremer Hospital,
Bellville, CP, were used. Of these 21 animals, 6 were
untreated controls, 9 received 2·0 ml. SKCF intramuscu-
larly on alternate days and 6 received 0-2 ml. SKCF
intramuscularly on alternate days. Single kidney allografts
were inserted in the e animals under ,'outine sterile condi-
tion . Five additional unoperated animals were given intra-
muscular subcellular kidney cell fractions (2'0 m!. every
alternate day) similar to the treated allotransplanted ani-
mals. All animals were compatible in terms of their
major human ABO erythrocyte blood groups. The ani-
mals were selected from heterogenic groups from western
Cape Province to avoid possible effects of inbreeding. De-
tails of anae thesia and operative techniques have been
described previously.'" Methods of pre- and postopera-
tive measurement of haematocrit, renal plasma flow and
creatinine clearance have also been described." All ani-
mal were eventually subjected to po tmortem examina-
tion which included full hi topathological studies.
Subcellular kidney cell fractions (SKCF) were prepared
as follows: Pooled, whole baboon kidneys were stored in
a deep-freeze unit, until time of homogenization, at
- 20°C. The capsules were removed after thawing, and the
kidneys were washed in Hanks balanced salt solution and
cut into mall fragments. These pieces were washed in
cold saline and then homogenized in a mechanical homo-
genizer for 15 min. at 50,000 t.p.m. The homogenizer
was kept cool by means of circulating cold tap-water.
The homogenate wa then placed in a ornc disintegrator
for 10 minutes with vibrations of about 8 kc.jsec. A
smear wa then made and examined micro copically to
en ure that all the cell had been ruptured. Finally, all
the homogenates were pooled and sterility tests performed,
and standardization was achieved by simple viscosity
measurements. All the homogenates were diluted with
Hanks balanced salt solution up to the point where it was
possible to pa s them through a o. 19-9auge injection
needle. Two renal allotransplanted groups were given SKCF
0·2 or 2·0 ml. on alternate days postoperatively until
death. An additional group of intact non-operated ani-
'Date received: 10 March t969.
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20 ± 21 days and had diminution of characteristic renal
allograft microscopic rejection features (Table 1)." One
animal from this group lived 89 days postoperatively.
The third group of 6 animals receiving 0·2 m!. SKCF
intramuscularly on alternate days survived 16 ± 9 days
(Table I). The decrease in the degree of renal morpho-
logical rejection was less marked in this group than in the
preceding group. None of the 5 unoperated animals that
received SKCF injections died during the period that
they were receiving these injections.
Renal Function
The dose-related increased survival in the animals
which received SKCF was also associated with improved
levels of postoperative renal plasma flow (RPF) and
creatinine clearance (GFR) (Table 11). This increase was
most apparent in the group receiving 2·0 ml. SKCF on
alternate days. In the group receiving 0'2 m!. SKCF renal
function was more similar to the untreated allotrans-
planted control, except that some animals from thi
group were still living 3 week postoperatively, although
with reduced levels of RPF and G FR. Only in the un-
treated animals at 2 weeks after renal allografting was
significant anaemia (Hct<20 0 0 ) detected (Table ll). All
other animals were non-anaemic (Hct>25 vols.oo )
during their total postoperative survival times. In our
experience in the intact baboon, with intact kidneys, ESF
is released in response to acute or intermittent bleeding
only when the haematocrit is below 20 vols. 00."
Erythropoietin (ESF)
Table III summarizes the erythropoietic (ESF) actIvIty
seen in the untreated and SKCF-treated baboon. Un-
treated animal had a progres ive postoperative rise in
ESF associated with a progressive decline in RPF and
G FR due to graft rejection. At 2 weeks after renal tran -
plantation the ESF levels were 16·2 times greater than in
saline controls (Table Ill). Pre-operative values in the
TABLE 11. RE 'AL FUNCTION AND HAEMATOLOGICAL STATUS IN TREATED A D U 'TREATED BABOON
RENAL ALLOGRAFTS*
Values Untreated SKCF(2'0 ml.) SKCF (0'2 ml.)
Pre-operative values
RPFt (ml./min.) 175 ± 28 140·5 ± 40·6 151·6 ± 42·5
Ccr:;: (ml./min.) 38·3 I 9·8 46·8 ± 11·7 34·5 ± 15·9
Het (vols. %) 36·6 == 6·6 41·8 ± 3·4 38·6 ± 3·6
Body-wt (kg.) 12·5 ± 5·8 13·8 ± 1-4 12·9 :f 4·8
Postoperative values
I week: RPF (ml./min.) 59 ± 11·7 93·7 ± 6·7 50·0 ± 3· I
Cer (ml./mjn.) 17·3 ± 7·9 19·8 ± 11·6 13·4 ± 6·4
Het (vols.%) 33·6 == 5 ·1 32·5 == 5·7 30·5 ± 2·1
2 weeks: RPF (ml./min.) 60 -l... 10·2 65 -l... 2·5 46·5 ± 4·1
Cer (ml./min.) 10·6 ± 3·8 13·5 == 2 5·4 ± 4·6
Het (vols. %) 18·0 ± 1·0 25·4 ± 8·5 32·5 ± 2'1
3 weeks: RPF (ml./min.) 65 ± 21 22·5 ± 12
Cer (ml./min.) 4·7 ± 4·4 5·0 ± 0·4
Het (vols. %) 35·3 ± 3·0 42·7 ± 5·7
• All values are mean (± 1 SD).
t RPF = renal plasma flow.
:t Ccr = endogenous creatinine clearance.




































;'Fe % ;'Fe %
uptake Ratio uptake Ratio
1·74 9·75
± 2·90 ± 16·2
0·40 0·75
14·47 17·44









• Values are mean == SEM unless otherwise indicated.
t 24-hour % "Fe uptake in polycythaemic HalICR Swiss mice.
24-hour % "Fe uptake (Iesl plasma)
; Ratio of Saline controls averaged 0·60 :::: O'15~{ 24-hour "'Fe uptake.
24-hour % uFe uptake (saline control)
•• Unoperaled. SKCF-injecled (10-14 days) group.
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same animals were only I -42 times greater than the
saline-injected mice. In contrast, animals treated with
2·0 m!. SKCF had values at all postoperative periods
which were 25 times or more greater than those of
plethoric aline-injected mice (Table Ill). These sus-
tained ESF elevations did not correlate with renal func-
tional (Table 11) or morphological evidence of graft re-
jection. The values were increased at the time of death,
but were similarly elevated at I and 2 week after allo-
transplantation.
ESF levels in the animals treated with 0·2 m!. SKCF
were not elevated in the early postoperative period. The
levels at I week and 2 weeks were less than those of the
untreated controls. Elevated ESF levels were, however.
present in tho e animal urviving 3 weeks after renal
tran plantation, before death from rejection. noperated,
SKCF-injected (2,0 m!. SKCF) baboons had elevations in
ESF activity above other pre-operative specimens ob-
tained from baboons not treated with SKCF. The SKCF-
injected animal (Table HI) had values over 2·5 times
above those of control or non-SKCF-injected pre-operative
baboons.
DISCUSSIO
Erythropoietin (ESF) release i a sociated with a
measured decline of renal function, and progressive histo-
logical evidence of renal graft rejection. The present re-
ults are similar to other untreated baboon allografts in
this regard: Thi series of animals (Table 1) had no
detectable renal anastomotic va cular ob tructions
present. The ESF elevations are therefore in part re-
latable to the intrarenal alterations or to the treatment
per se. The measured kidney functions (Table 1I) con-
firm the renal ischaemia which was progressive and re-
latable to the typical micro copic appearance of rejec-
tion." ]t is not apparent, however, on the basis of the
aforementioned evidence, why, on a dose-related basis,
SKCF (subcellular kidney fraction) treatment should be
associated with sustained ESF elevations when admini-
tered to renal-allografted baboons. These ESF elevations
were marked (Table HI) and apparent both early and late
in the postoperative period. The higher do e does not
correlate with the level of renal function observed or
diminution in histological evidence of renal rejection in
this same group." SKCF injections into intact rabbits do
not induce a plethoric state." Doses above 2'0 m!. SKCF
are associated with intravascular agglutinations due to
the apparent properties of the preparation."'" This limit
the further te ting of the do e relationship of SKCF ad-
ministration and ESF in baboon renal allografts.
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However, noticeable erythropoietic effect is seen when
SKCF is given to unoperated, intact baboons. A renal
erythropoietic factor (REF)" has been characterized by
Gordon and a sociates. REF is found in the renal tissue,
and has been further characterized by additional bio-
chemical techniques." ]t appears that the present SKCF
preparation, in sufficient amounts, may contain REF or
other stimulants to ESF which, when administered to
intact non-operated or renal allografted baboons, results
in erythropoietin release or activation. This is not direct-
ly relatable to the degree of renal rejection or level of
kidney function. Other unmonitored hormonal alterations
may be operative and must be further characterized.
SUMMARY
Erythropoietin (ESF) is released in increased amounts from
untreated baboon renal allografts. ESF levels correlate well
with the decline in renal plasma flow, and glomerular filtration
rate. Treatment with subcellular kidney cell fractions (SKCF)
prolongs survival, improves renal function, and diminishes
morphological graft rejection features on a dose-related basis.
ESF is, however, always 25 times or greater above control levels
in high-dose, renal-transplanted, SKCF-treated animals. SKCF
injection to unoperat~d baboons also augments ESF responses.
The ESF el~vations are believed to be due to r~Iease or
stimulation of renal erythropoietic factor (REF), or erythro-
poietin precursors in the baboon allografts by SKCF.
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